تاثیر ملاتونین بر مارکر های کبدی و کلیوی رت های دیابتی شده با استرپتوزوتوسین
  •   آرشیو : نسخه پاییز و زمستان 1399
  •   نوع مقاله : پژوهشی
  •   کد پذیرش : 1252
  •   موضوع : موضوعی تعریف نشده!
  • نویسنده/گان : حامد صفرزاده سراسکانرود، فلور زرگری
  •   کلید واژه : ملاتونین، مارکرهای کبدی، استرپتوزوتوسین، بیوشیمی.
  •   مراجع :
    1. Halliwell B. Reactive oxygen species in living systems: source, biochemistry, and role in human disease. The American journal of medicine. 1991;91(3):S14-S22.
    2. Halliwell B. The chemistry of oxygen radicals and other oxygen-derived species. Free radicals in biology and medicine. 1989.
    3. Gutteridge J. Hydroxyl radicals, iron, oxidative stress, and neurodegeneration. Annals of the New York Academy of Sciences. 1994;738(1):201-13.
    4. Feig DI, Reid TM, Loeb LA. Reactive oxygen species in tumorigenesis. Cancer Research. 1994;54(7 Supplement):1890s-4s.
    5. Rodriguez C, Mayo JC, Sainz RM, Antolin I, Herrera F, Martin V, et al. Regulation of antioxidant enzymes: a significant role for melatonin. Journal of pineal research. 2004;36(1):1-9.
    6. Mullarkey CJ, Edelstein D, Brownlee M. Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochemical and biophysical research communications. 1990;173(3):932-9.
    7. Sanders RA, Rauscher FM, Watkins JB. Effects of quercetin on antioxidant defense in streptozotocin‐induced diabetic rats. Journal of Biochemical and Molecular Toxicology. 2001;15(3):143-9.
    8. West IC. Radicals and oxidative stress in diabetes. Diabetic Medicine. 2000;17(3):171-80.
    9. Hunt JV, Bottoms MA, Mitchinson MJ. Oxidative alterations in the experimental glycation model of diabetes mellitus are due to protein-glucose adduct oxidation. Some fundamental differences in proposed mechanisms of glucose oxidation and oxidant production. Biochemical Journal. 1993;291(Pt 2):529.
    10. Scheer FA, Van Montfrans GA, Van Someren EJ, Mairuhu G, Buijs RM. Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension. Hypertension. 2004; 43: 192-197.
    11. Hale sayan,etal.Beneficial effects of melatonin on reperfusion injury in rat sciatic. J Pineal Res.2004;37:143-148.
    12. Farias J.G, Zepeda A.B, Calaf G.M. Melatonin protects the heart, lungs and kidneys from oxidative stress under intermittent hypobaric hypoxia in rats. Biol Res. 2012;45:81-85.
    13. Demirbag R, Yilmaz R, Guzel S, Celik H, Kocyigit A, Ozcan E. Effects of treadmill exercise test on oxidative/ antioxidative parameters and DNA damage. Anadolu Kardiyol Derg. 2006; 6:135-140.
    14. Sanchez-Mateos S,etal.Melatonin and estradiol effects on food intake, body weight, and leptin in ovariectomized rate.j Maturitas the European menopause.2007; 58: 91-101.
    15. Tamura H, Nakamura Y, Terron MP, etal. Melatonin and pregnancy in the human. Reprod Toxicol.2008; 25:291-303.
    16. She M, Etal. A novel melatonin agonist, inhibits weight gain and improves insulin sensitivity in high-fat/ high- sucrose- fed rats. Pharmacol Res. 2009; 59: 248-253.
    17. Rios-lugo MJ, etal. Melatonin effect on plasma adiponectin, leptin, insulin, glucose, triglycerides and cholesterol in normal and high fat-fed rats. J Pineal Res. 2010; 49:342-348.
    18. Nduhirabandi F, etal. Chronic melatonin consumption prevents obesity- related metabolic abnormalities and protects the heart against myocardial ischemia and reperfusion injury in a prediabetic model of dietinduced obesity. J Pineal Res.2011; 50:171-182.
    19. Agil A, Navarro-Alarcon M, Ruiz R, Abuhamadah S, El Mir MY, VazquezGF. Beneficial effects of melatonin on obesity and lipid profile in young zucker diabetic fatty rats. J Pineal Res DOI .2010;10:234-239.
  •  صفحات : 18-26
  •   دانلود فایل ( 703.54 KB )